01498 PURAPHARM
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.55X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 89.6% | Net Margin | N/A |
Total Debt/Equity | 327.1% | Return on Equity | N/A |
Price/Book | 1.58X | Return on Assets | N/A |
(HKD 0.445) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -35.44 | -106.08 | -120.21 | -121.88 | 31.71 |
---|---|---|---|---|---|
Net Profit Growth (%) | +66.6 | +11.8 | +1.4 | -484.4 | +114.0 |
Earnings Per Share (HKD) | -0.09 | -0.269 | -0.305 | -0.31 | 0.086 |
Earnings Per Share Growth (%) | +66.6 | +11.9 | +1.6 | -462.0 | +109.8 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | 5.20 |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.281 | 0.387 | 0.652 | 1.017 | 1.296 |
Auditors' Opinion | Unqualified # | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 382.09 | 406.859 | -6.1 | 448.069 |
Operating Result | -28.832 | -102.167 | -71.8 | -119.182 |
Associates | -0.312 | -0.145 | +115.2 | 0 |
Profit Before Taxation | -29.144 | -102.312 | -71.5 | -119.182 |
Taxation | 6.295 | 3.769 | +67.0 | 1.032 |
Profit /( Loss) After Taxation | -35.439 | -106.081 | -66.6 | -120.214 |
Net Profit | -35.439 | -106.081 | -66.6 | -120.214 |
Earnings Per Share () | -0.0897 | -0.2685 | -66.6 | -0.3047 |
Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-21 |
* Annualised
Last Update Time: 2025-07-22 21:40:25